{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:55:06Z","timestamp":1793858106759,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.neuropharm.2019.107788","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T18:41:03Z","timestamp":1569264063000},"page":"107788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers"],"prefix":"10.1016","volume":"170","author":[{"given":"Mary R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-4212","authenticated-orcid":false,"given":"Mehdi","family":"Farokhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Cobbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian T.","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Farinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Akhlaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107788_bib1","doi-asserted-by":"crossref","first-page":"306510","DOI":"10.4061\/2011\/306510","article-title":"The central effects of thyroid hormones on appetite","volume":"2011","author":"Amin","year":"2011","journal-title":"J. Thyroid Res."},{"key":"10.1016\/j.neuropharm.2019.107788_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/alcalc\/agu085","article-title":"Relationship between the thyroid axis and alcohol craving","volume":"50","author":"Aoun","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2019.107788_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/ml400473x","article-title":"Discovery of PF-5190457, a potent, selective, and orally bioavailable ghrelin receptor inverse agonist clinical candidate","volume":"5","author":"Bhattacharya","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2019.107788_bib4","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jcem.86.10.8098","article-title":"Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans","volume":"86","author":"Broglio","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2019.107788_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bcp.13127","article-title":"Pharmacokinetics and pharmacodynamics of PF-05190457: the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects","volume":"83","author":"Denney","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107788_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.physbeh.2019.02.008","article-title":"Ghrelin: from a gut hormone to a potential therapeutic target for alcohol use disorder","volume":"204","author":"Farokhnia","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2019.107788_bib7","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/mp.2017.226","article-title":"Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals","volume":"23","author":"Farokhnia","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107788_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881116684338","article-title":"Altering ethanol pharmacokinetics to treat alcohol use disorder: can you teach an old dog new tricks?","volume":"31","author":"Haass-Koffler","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107788_bib9","doi-asserted-by":"crossref","first-page":"pyw048","DOI":"10.1093\/ijnp\/pyw048","article-title":"Serum insulin levels are reduced by intravenous ghrelin administration but do not correlate with alcohol craving in alcohol-dependent individuals","volume":"19","author":"Haass-Koffler","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107788_bib10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.107788_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.11.005","article-title":"Gut-brain axis and addictive disorders: a review with focus on alcohol and drugs of abuse","volume":"196","author":"Jerlhag","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107788_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuropharm.2019.107788_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11065-012-9209-y","article-title":"The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans","volume":"22","author":"Kenna","year":"2012","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neuropharm.2019.107788_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1530\/EJE-10-0094","article-title":"Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma","volume":"162","author":"Kluge","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neuropharm.2019.107788_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107788_bib16","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bph.13439","article-title":"Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo","volume":"173","author":"Kong","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107788_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.psyneuen.2017.08.005","article-title":"Drinking water to reduce alcohol craving? A randomized controlled study on the impact of ghrelin in mediating the effects of forced water intake in alcohol addiction","volume":"85","author":"Koopmann","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107788_bib18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/acer.12814","article-title":"Effect of functionally significant deiodinase single nucleotide polymorphisms on drinking behavior in alcohol dependence: an exploratory investigation","volume":"39","author":"Lee","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2019.107788_bib19","article-title":"The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study","author":"Lee","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107788_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1358\/dnp.2010.23.3.1429490","article-title":"Role of the ghrelin system in alcoholism: acting on the growth hormone secretagogue receptor to treat alcohol-related diseases","volume":"23","author":"Leggio","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2019.107788_bib21","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1530-0277.2008.00792.x","article-title":"Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study","volume":"32","author":"Leggio","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2019.107788_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","article-title":"Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation","volume":"76","author":"Leggio","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107788_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000123544","article-title":"Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat","volume":"37","author":"Lin","year":"1983","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107788_bib24","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/acer.13781","article-title":"Stress, motivation, and the gut-brain Axis: a focus on the ghrelin system and alcohol use disorder","volume":"42","author":"Morris","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2019.107788_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"Muller","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.neuropharm.2019.107788_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0016-5085(83)80027-4","article-title":"Pancreatic polypeptide: a hormone under vagal control","volume":"85","author":"Schwartz","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2019.107788_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/dom.12952","article-title":"Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans","volume":"19","author":"Tamboli","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.neuropharm.2019.107788_bib28","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2337\/db10-0504","article-title":"Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans","volume":"59","author":"Tong","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.107788_bib29","series-title":"Human Metabolism of Alcohol","first-page":"41","article-title":"Total body water and blood alcohol levels: updating the fundamentals","volume":"vol. 1","author":"Watson","year":"1989"},{"key":"10.1016\/j.neuropharm.2019.107788_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.irn.2017.08.002","article-title":"The role of the ghrelin system in drug addiction","volume":"136","author":"Zallar","year":"2017","journal-title":"Int. Rev. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819303466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819303466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:06:34Z","timestamp":1758438394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819303466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":30,"alternative-id":["S0028390819303466"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107788","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107788"}}